U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07735858) titled 'Microfluidic Urinary Exosome-Based Diagnostic Model for Bladder Cancer' on July 25.
Brief Summary: Bladder cancer is one of the most common malignancies of the urinary system and is characterized by high recurrence rates and poor long-term outcomes. Early detection and accurate diagnosis are essential for improving clinical management.
This prospective diagnostic accuracy study aims to develop and validate a precision diagnostic model for bladder cancer based on microfluidic isolation and multiplex detection of urinary exosomes.
A novel microfluidic platform will be developed for rapid and efficient urinary exosome enrichment. Mul...